BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 16001399)

  • 21. Second-generation antisense oligonucleotides against β-catenin protect mice against diet-induced hepatic steatosis and hepatic and peripheral insulin resistance.
    Popov VB; Jornayvaz FR; Akgul EO; Kanda S; Jurczak MJ; Zhang D; Abudukadier A; Majumdar SK; Guigni B; Petersen KF; Manchem VP; Bhanot S; Shulman GI; Samuel VT
    FASEB J; 2016 Mar; 30(3):1207-17. PubMed ID: 26644352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibiting monoacylglycerol acyltransferase 1 ameliorates hepatic metabolic abnormalities but not inflammation and injury in mice.
    Soufi N; Hall AM; Chen Z; Yoshino J; Collier SL; Mathews JC; Brunt EM; Albert CJ; Graham MJ; Ford DA; Finck BN
    J Biol Chem; 2014 Oct; 289(43):30177-88. PubMed ID: 25213859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diacylglycerol acyltranferase 1 anti-sense oligonucleotides reduce hepatic fibrosis in mice with nonalcoholic steatohepatitis.
    Yamaguchi K; Yang L; McCall S; Huang J; Yu XX; Pandey SK; Bhanot S; Monia BP; Li YX; Diehl AM
    Hepatology; 2008 Feb; 47(2):625-35. PubMed ID: 18000880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roles of Acyl-CoA:Diacylglycerol Acyltransferases 1 and 2 in Triacylglycerol Synthesis and Secretion in Primary Hepatocytes.
    Li C; Li L; Lian J; Watts R; Nelson R; Goodwin B; Lehner R
    Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1080-91. PubMed ID: 25792450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbenoxolone treatment attenuates symptoms of metabolic syndrome and atherogenesis in obese, hyperlipidemic mice.
    Nuotio-Antar AM; Hachey DL; Hasty AH
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1517-28. PubMed ID: 17878220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2.
    Savage DB; Choi CS; Samuel VT; Liu ZX; Zhang D; Wang A; Zhang XM; Cline GW; Yu XX; Geisler JG; Bhanot S; Monia BP; Shulman GI
    J Clin Invest; 2006 Mar; 116(3):817-24. PubMed ID: 16485039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic knockdown of mitochondrial GPAT1 in ob/ob mice improves metabolic profile.
    Xu H; Wilcox D; Nguyen P; Voorbach M; Suhar T; Morgan SJ; An WF; Ge L; Green J; Wu Z; Gimeno RE; Reilly R; Jacobson PB; Collins CA; Landschulz K; Surowy T
    Biochem Biophys Res Commun; 2006 Oct; 349(1):439-48. PubMed ID: 16935266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coenzyme A: diacylglycerol acyltransferase 1 inhibitor ameliorates obesity, liver steatosis, and lipid metabolism abnormality in KKAy mice fed high-fat or high-carbohydrate diets.
    Yamamoto T; Yamaguchi H; Miki H; Shimada M; Nakada Y; Ogino M; Asano K; Aoki K; Tamura N; Masago M; Kato K
    Eur J Pharmacol; 2010 Aug; 640(1-3):243-9. PubMed ID: 20478303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction of hepatosteatosis and lipid levels by an adipose differentiation-related protein antisense oligonucleotide.
    Imai Y; Varela GM; Jackson MB; Graham MJ; Crooke RM; Ahima RS
    Gastroenterology; 2007 May; 132(5):1947-54. PubMed ID: 17484887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice.
    Cong WN; Tao RY; Tian JY; Liu GT; Ye F
    Life Sci; 2008 May; 82(19-20):983-90. PubMed ID: 18417155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
    Bousette N; D'Orleans-Juste P; Kiss RS; You Z; Genest J; Al-Ramli W; Qureshi ST; Gramolini A; Behm D; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
    Circ Res; 2009 Sep; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of triglyceride synthesis as a treatment strategy for obesity: lessons from DGAT1-deficient mice.
    Chen HC; Farese RV
    Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):482-6. PubMed ID: 15569818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonalcoholic hepatic steatosis in Zucker diabetic rats: spontaneous evolution and effects of metformin and fenofibrate.
    Forcheron F; Abdallah P; Basset A; del Carmine P; Haffar G; Beylot M
    Obesity (Silver Spring); 2009 Jul; 17(7):1381-9. PubMed ID: 19553925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Green tea (-)-epigallocatechin-3-gallate reduces body weight with regulation of multiple genes expression in adipose tissue of diet-induced obese mice.
    Lee MS; Kim CT; Kim Y
    Ann Nutr Metab; 2009; 54(2):151-7. PubMed ID: 19390166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peripheral reduction of FGFR4 with antisense oligonucleotides increases metabolic rate and lowers adiposity in diet-induced obese mice.
    Yu XX; Watts LM; Manchem VP; Chakravarty K; Monia BP; McCaleb ML; Bhanot S
    PLoS One; 2013; 8(7):e66923. PubMed ID: 23922646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease.
    Hong F; Radaeva S; Pan HN; Tian Z; Veech R; Gao B
    Hepatology; 2004 Oct; 40(4):933-41. PubMed ID: 15382116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ursodeoxycholic acid improves insulin sensitivity and hepatic steatosis by inducing the excretion of hepatic lipids in high-fat diet-fed KK-Ay mice.
    Tsuchida T; Shiraishi M; Ohta T; Sakai K; Ishii S
    Metabolism; 2012 Jul; 61(7):944-53. PubMed ID: 22154323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histidine and carnosine alleviated hepatic steatosis in mice consumed high saturated fat diet.
    Mong MC; Chao CY; Yin MC
    Eur J Pharmacol; 2011 Feb; 653(1-3):82-8. PubMed ID: 21167151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo knockdown of p85alpha with an antisense oligonucleotide improves insulin sensitivity in Lep(ob/ob) and diet-induced obese mice.
    Moriarty MW; McCurdy CE; Janssen RC; Shaw T; Leitner JW; Friedman JE; Draznin B
    Horm Metab Res; 2009 Oct; 41(10):757-61. PubMed ID: 19598077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conjugated linoleic acid does not reduce body fat but decreases hepatic steatosis in adult Wistar rats.
    Purushotham A; Shrode GE; Wendel AA; Liu LF; Belury MA
    J Nutr Biochem; 2007 Oct; 18(10):676-84. PubMed ID: 17368879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.